B. Braun Melsungen AG — Vulnerabilities & Security Advisories 17

B. Braun Melsungen AG, a leading medical technology and pharmaceutical company, develops healthcare products including infusion pumps and drug delivery systems. Historically, their devices have faced vulnerabilities like remote code execution, cross-site scripting, and privilege escalation, often stemming from inadequate input validation and weak authentication. Security researchers have identified multiple CVEs in their products, with some instances allowing unauthorized access to sensitive patient data or device manipulation. While no major public security incidents have been widely reported, the consistent presence of vulnerabilities in their medical devices highlights ongoing challenges in securing critical healthcare infrastructure against evolving cyber threats.